These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genome editing: the road of CRISPR/Cas9 from bench to clinic. Eid A; Mahfouz MM Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9: an advanced tool for editing plant genomes. Samanta MK; Dey A; Gayen S Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546 [TBL] [Abstract][Full Text] [Related]
6. Genome Editing and Pathological Cardiac Hypertrophy. Kato T Adv Exp Med Biol; 2023; 1396():87-101. PubMed ID: 36454461 [TBL] [Abstract][Full Text] [Related]
7. [CRISPR/Cas9 technology in disease research and therapy: a review]. Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436 [TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements. Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W Cells; 2022 Nov; 11(22):. PubMed ID: 36429042 [TBL] [Abstract][Full Text] [Related]
12. Application of CRISPR-Cas systems in neuroscience. Bonnerjee D; Bagh S Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599 [TBL] [Abstract][Full Text] [Related]
13. The era of editing plant genomes using CRISPR/Cas: A critical appraisal. Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369 [TBL] [Abstract][Full Text] [Related]
14. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Rasoulinejad SA; Maroufi F Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656 [TBL] [Abstract][Full Text] [Related]
15. Construction and Evaluation of Zinc Finger Nucleases. Ochiai H; Yamamoto T Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134 [TBL] [Abstract][Full Text] [Related]
16. CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases. Dong M; Liu J; Liu C; Wang H; Sun W; Liu B Pharmacol Res; 2022 Nov; 185():106480. PubMed ID: 36191879 [TBL] [Abstract][Full Text] [Related]
17. Gene editing and CRISPR in the clinic: current and future perspectives. Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531 [TBL] [Abstract][Full Text] [Related]
18. Gene Editing With TALEN and CRISPR/Cas in Rice. Bi H; Yang B Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502 [TBL] [Abstract][Full Text] [Related]